For this week’s Biorasi Spotlight, meet Mark Vieder, RPH, MBA, Vice President of Drug Safety and Pharmacovigilance at Biorasi, LLC.

1. How did you get into clinical research?
Being a health care professional (HCP) and having practiced for a number of years, I accidentally fell into the research side of health care. A company was searching for HCPs to assist with their safety reporting and after multiple discussions I found myself intrigued and excited with the research environment and the impact it has on health care.

 

2. What is your favorite part of the job?
Actually, there are multiple aspects that are favorites of mine, starting with the fact that the work we do is impactful to the health and wellbeing of patients. While not an immediate impact as when I was practicing but an impact that has long term benefits for the patients we ultimately serve. Along with that and within the realm of safety and pharmacovigilance it is the opportunity to have discussions with a wide array of other HCP who are as dedicated and strive to ensure that when medications are in the testing phase or available on the market for millions to use that they are as safe as they can be.

 

3. What are your biggest challenges on the job?
The biggest challenge on my job is that it is an ongoing and continuous aspect that we need to be mindful of.  As medications go through the clinical phase and ultimately to approval the safety component of these products needs to be monitored, reported and evaluated to ensure the continued safe use of these medications.

 

4. What are the keys to success in your job?
The keys to success in the safety environment is being vigilant, open minded and having the resources needed to monitor, report and evaluate medications that are being developed and already utilized by many patients. Resources in personnel and the tools needed to be able to gather the information logically and accurately allowing the vigilance to occur.

 

5. Tell us something interesting about yourself?
Becoming a health care professional, I can say seems to be the “family” business as throughout my family we are all involved in health care and wanting to ensure not only internally (family) are patients taken care of but also externally (research and/or practicing). So from my brothers, to my sons to my nephews to myself we all have an avid interest in ensuring the safety and wellbeing of the patients we come in contact with and the ones we can assist from a distance.